Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Zinc undecylenate, Undecylenic acid may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
this medicine Apply it to the skin. Avoid contact with the eyes, nose and mouth.
0
Adults, the elderly and children
Treatment of Athlete's Foot ¢ Wash and dry the foot thoroughly each morning and night. ¢ Smooth the cream onto the affected area. ¢ Take care to make sure the cream is massaged between the toes and then dust with Mycota Powder. ¢ Wear clean socks or stockings each day dusted inside with Mycota Powder. ¢ Continue this treatment for one week after all signs of infection have disappeared. Prevention of Athlete's Foot ¢ Rub in the cream and dust socks or stockings inside with Mycota Powder each day.
Important information about some
of the ingredients
This product contains: ¢ cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis). ¢ sodium laurilsulfate may cause local skin reactions (such as stinging or burning sensation) or increase skin reactions caused by other products when applied on the same area. ¢ euganol, which may cause an allergic reaction.
If you swallow some If you accidentally swallow some, see a doctor straight away. Take the pack with you to show which medicine you have swallowed.
Turn over
92764792009
4. Possible side effects
6. Further information
Like all medicines, Mycota Cream can have side effects, although these don't affect everyone. ¢ Allergic reactions (rash, itching, wheezing) may occur. ¢ Rarely, irritation of the skin may occur.
What is in this medicine
If you notice these or any other side effect not included above, stop use and tell your doctor or pharmacist. They will tell you what to do. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
5. Storing this medicine ¢ Keep it out of the sight and reach of children. ¢ There are no special conditions for storing this medicine. ¢ Do not use after the expiry date shown on the carton. The expiry date refers to the last day of that month. ¢ Medicine should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of any unused medicine. These measures will help to protect the environment.
The active ingredients are: zinc undecylenate 20% w/w, undecylenic acid 5% w/w. The other ingredients are: liquid paraffin, emulsifying wax (contains cetosteary! alcohol and sodium laurilsulfate), perfume compound (contains euganol), purified water. What the medicine looks like Mycota Cream is an off-white cream with a characteristic smell. It is supplied in 25g tubes.
Marketing authorisation holder and manufacturer Thornton and Ross Ltd., Huddersfield,
HD7 5QH, UK. This leaflet was last revised in
September 2020 Mycota is a trade mark of Thornton and Ross Ltd.
92764792009
Mycota Cream comes as cream. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Mycota Cream is zinc undecylenate, undecylenic acid.
This leaflet reproduces the patient information leaflet approved for Mycota Cream, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the treatment and prevention of athlete's foot
Adults, Children and Elderly
Treatment
Each night and morning wash thoroughly dry the foot, then smooth the cream on to the affected area. Take particular care to ensure the cream is massaged between the toes then dust with Mycota Powder. Wear clean socks or stockings each day dusted inside with Mycota Powder. Continue this treatment for one week after all signs of infection have disappeared.
Prevention
Each day rub in Mycota Cream and dust socks or stockings inside with Mycota Powder.
Hypersensitivity to any of the ingredients
The label states for external use only, keep all medicines out of the sight and reach of children.
Contact with the eyes and mucous membranes should be avoided.
Treatment should be discontinued if irritation is severe.
Do not apply to broken skin.
Excipient warnings:
This medicine contains Emulsifying wax with 1.4% w/w Sodium laurilsulfate. Sodium laurilsulfate may cause local skin reactions (such as stinging or burning sensation) or increase skin reactions caused by other products when applied on the same area.
This medicine contains Emulsifying wax with 1.36% w/w Cetostearyl alcohol. Cetosteryl alcohol may cause local skin reactions (e.g. contact dermatitis).
This medicine contains fragrance with Euganol, which may cause an allergic reaction.
No clinically significant drug interactions known
Although there is no specific data available concerning the use of Mycota Cream during pregnancy and lactation, it is not considered to constitute a hazard.
No adverse effects known
Hypersensitivity reactions may occasionally occur. Irritation of the skin may rarely occur.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Excessive application to the skin is unlikely to cause untoward effects. In the unlikely event of ingestion of Mycota Cream symptoms of overdosage may include nausea, vomiting, diarrhoea and general gastrointestinal disturbances. Treatment need only be symptomatic.
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Mycota Cream. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.